Studying the association between sarcopenia and adverse outcomes in the elderly

  • Huỳnh Trung Quốc Hiếu Đại học Y Dược Thành phố Hồ Chí Minh

Main Article Content

Keywords

Sarcopenia, adverse outcomes, elderly

Abstract

Objective: To analyze the association between sarcopenia (diagnosed according to AWGS 2019) and some adverse health outcomes in the elderly living in District 9, Ho Chi Minh City, after six months of follow-up. Subject and method: A prospective cohort study of two study groups (584 elderly ≥ 60-year-olds) with and without sarcopenia and recorded adverse outcomes after six months (death, hospitalization, falls). The period from 10/2020–06/2021. Result: The average age of the study sample was 69.57 ± 7.25 years, 30% of men. The proportion of severe sarcopenia, sarcopenia, and non-sarcopenia were: 4.97%, 48.63% and 46.40%, respectively. The ratio of the component criteria for evaluating sarcopenia according to AWGS 2019: a decrease in muscle mass by 55.65%, a decrease in muscle strength by 61.82%, and a decrease in physical activity by 17.98%. Older adults with sarcopenia were 1.77 times more likely to develop adverse outcomes (death, hospitalization, falls) than older adults without sarcopenia (p<0.001; 95% CI: 1.31-2.39). At the same time, reducing physical activity through the 6m walking test was associated with the risk of adverse outcomes in the elderly (RR = 1.40; 95% CI: 1.02-1.92, p=0.036), decreased muscle mass (measured by BIA method), was also associated with adverse outcomes in the elderly (RR = 1.78, 95% CI: 1.31-2.43, p<0.001). Conclusion: Sarcopenia is associated with a higher risk of adverse health outcomes (death, hospitalization, falls) in older adults living in the community, while decreased physical activity (walking tets 6m < 1m/s), reduced muscle mass (measured by BIA method) is also associated with an increased risk of adverse outcomes.

Article Details

References

1. Nguyễn Ngọc Tâm, Nguyễn Trung Anh, Phạm Thắng, Vũ Thị Thanh Huyền (2020) Tìm hiểu một số yếu tố liên quan với sarcopenia ở người bệnh cao tuổi. Tạp chí Nghiên cứu Y học, 6, tr. 112-118.
2. Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyère O (2017) Health outcomes of sarcopenia: A systematic review and meta-analysis. PloS one 12(1): 0169548.
3. Chen LK, Woo J, Assantachai P et al (2020) Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21(3): 300-307.
4. Cesari M, Kritchevsky SB, Penninx BWHJ et al (2005) Pronostic value of usual gait speed in well-functioning older people. Results from the Health, aging and body composition study. J Am Geriatr Soc 53: 1675-1680.
5. Giang LT, Nguyen NT et al (2020) Social support effect on health of older people in Vietnam: Evidence from a national aging survey. Ageing International 45(4): 344-360
6. Morley JE (2012) Sarcopenia in the elderly. Fam Pract 29(1): 44-48.
7. Nguyen TN, Nguyen TN, Nguyen AT et al (2020) Prevalence of sarcopenia and its associated factors in patients attending geriatric clinics in Vietnam: A cross-sectional study. BMJ open 10(9): 037630.
8. Nguyen AT, Nguyen HTT, Nguyen HTT et al (2022) Walking speed assessed by 4-meter walk test in the community-dwelling oldest old population in Vietnam. International journal of environmental research and public health 19(16): 9788.
9. Lam FM, Su Y, Lu ZH, Yu R, Leung JC, & Kwok TC (2020) Cumulative and incremental value of sarcopenia components on predicting adverse outcomes. Journal of the American Medical Directors Association 21(10): 1481-1489.